Navigation Links
2012 Hannover Messe: Innovations by KIT
Date:4/16/2012

This release is available in German.

At the 2012 Hannover Messe from April 23 to 27, KIT will present innovations relating to energy, mobility, IT, and other topics of relevance to the future. KIT will inform about its algae engineering platform and exhibit a photobioreactor for microalgae. In addition, new laser technologies for the production of lithium-ion batteries, an electronic drawbar for agricultural machines, and an organic computing system for tractors will be presented. Co-exhibitors will be KNMF, EUMINAfab, EnSoC, and KIC InnoEnergy. KIT will also contribute to other stands and special exhibitions.

Main KIT Stand, Hall 2, C18:

Algae as a source of energy. Microalgae act like small power plants: They convert a relatively large fraction of sunlight into chemical energy. Doing this, they take up large amounts of CO2 from the atmosphere. They can be cultivated in technical systems and, hence, do not require any arable areas and do not compete with food production. Certain microalgae contain high oil fractions or can produce hydrogen from water and sunlight. At KIT, several institutes focus on algae research. The KIT Platform for Algae Engineering covers the complete chain of use of algae as an energy source, from reactor development to solid-liquid separation and cell disintegration by electroporation to accompanying systems analysis. KIT researchers develop novel photobioreactors ensuring optimum use of light for highly efficient conversion of sunlight into biomass. The laboratory photobioreactor displayed is an angular gap reactor of 25 liters volume for the cultivation of microalgae. It is aerated with CO2 and air. The pH value, temperature, and gas supply can be controlled. The reactor is autoclavable.

Lasers for the production of lithium-ion batteries. Successful implementation of electromobility and stati
'/>"/>

Contact: Monika Landgraf
presse@kit.edu
49-721-608-47414
Helmholtz Association of German Research Centres
Source:Eurekalert  

Page: 1 2 3 4 5 6

Related biology technology :

1. Inverness Medical Innovations Features Innovative TB Diagnostic - Clearview(R) TB ELISA at AIDS 2008
2. Inverness Medical Innovations to Present at the Morgan Stanley Global Healthcare Unplugged Conference on September 9, 2008
3. Inverness Medical Innovations Declares Dividend on its Series B Convertible Perpetual Preferred Stock
4. Inverness Medical Innovations to Attend the Goldman Sachs Diagnostics Conference on September 18, 2008
5. Inverness Medical Innovations to Present at the UBS Global Life Sciences Conference on September 22, 2008
6. Inverness Medical Innovations Schedules Conference Call for 10:00 a.m. ET October 29, 2008 to Discuss Third Quarter 2008 Results
7. Inverness Medical Innovations Announces Third Quarter 2008 Results
8. Pharos Innovations Joins Partnership to Fight Chronic Disease
9. Nikon Instruments Perfect Focus System Wins Second Place in The Scientists Top Innovations of 2008 Award
10. Stem Cell Innovations, Inc., Files New Patent Application
11. Cleveland Clinic Selects Laparoendoscopic Single-Site Surgery (LESS) as One of the Top Ten Innovations of 2009
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
2012 Hannover Messe: Innovations by KIT
(Date:4/1/2015)... FREMONT, Calif. , April 1, 2015  ValGenesis ... Software solutions, announced today that it has completed its ... Section 101, Attest Engagements (AICPA, Professional Standards) for the ... 31 st 2014.  ... The ...
(Date:4/1/2015)... , Apr. 1, 2015 Goldman Small ... the small cap and microcap sectors, announced today that ... Inc. (OTCQB – PMCB), a publicly traded clinical stage ... cancer and diabetes. To view the sponsored research article, ... in its entirety, please visit www.GoldmanResearch.com .  ...
(Date:4/1/2015)... /PRNewswire/ - Portage Biotech Inc. ("Portage") (OTC Market: ... announce that Biohaven Pharmaceutical Holding Company Limited (Biohaven), ... an agreement with inVentiv Health for the operational ... lead compound (BHV-0223). Biohaven is ... stage neuroscience compounds targeting the glutamatergic system. Clinical ...
(Date:4/1/2015)... April 1, 2015  EMD Serono, the U.S. biopharmaceuticals ... , announced today the appointment of Frederick E. ... and Immunology. In this capacity, he will lead the ... projects and collaborations for Rebif ® (interferon beta-1a) ... Dr. Munschauer joins EMD Serono from ...
Breaking Biology Technology:ValGenesis Inc. Successfully Completes Service Organization Controls 2 (SOC 2) Report under AT Section 101 2ValGenesis Inc. Successfully Completes Service Organization Controls 2 (SOC 2) Report under AT Section 101 3Flurry of Biotech Mergers and Acquisitions Bodes Well for PharmaCyte Biotech 2Flurry of Biotech Mergers and Acquisitions Bodes Well for PharmaCyte Biotech 3Flurry of Biotech Mergers and Acquisitions Bodes Well for PharmaCyte Biotech 4Portage's Biohaven Announces Agreement with inVentiv Health 2Portage's Biohaven Announces Agreement with inVentiv Health 3EMD Serono Appoints Frederick E. Munschauer M.D., FAAN to Vice President of Medical Affairs, Neurology and Immunology 2EMD Serono Appoints Frederick E. Munschauer M.D., FAAN to Vice President of Medical Affairs, Neurology and Immunology 3EMD Serono Appoints Frederick E. Munschauer M.D., FAAN to Vice President of Medical Affairs, Neurology and Immunology 4EMD Serono Appoints Frederick E. Munschauer M.D., FAAN to Vice President of Medical Affairs, Neurology and Immunology 5
... and flat federal funding of biomedical research, five,important actions ... cost --,can yield dramatic results for patients and the ... (NCI) in a commentary published today by "The,Oncologist." , ... , In the article, James ...
... 07/06 2008 08/07, ... millions millions, ... 14, Other EU Countries 9.7 22 17 11.3 ... 3 10 2.0 4 45, SLIT ...
... Jan. 15 Regado Biosciences, Inc., announced today ... to the position of Senior Vice President, Clinical ... immediately. He will report to David J. ... Officer.Dr. Mazzo stated, "Steven has led clinical programs ...
Cached Biology Technology:National Cancer Institute: Battling Cancer and a Recession 2National Cancer Institute: Battling Cancer and a Recession 3Stallergenes: 2008: Sales Up 16% - Excellent Performance - Guidance Exceeded 2Stallergenes: 2008: Sales Up 16% - Excellent Performance - Guidance Exceeded 3Dr. Steven L. Zelenkofske Joins Regado Biosciences as Senior Vice President, Clinical and Medical Affairs and Chief Medical Officer 2Dr. Steven L. Zelenkofske Joins Regado Biosciences as Senior Vice President, Clinical and Medical Affairs and Chief Medical Officer 3
(Date:3/23/2015)... --NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or the "Company"), ... market, announces its biometric payment technology, the Wocket® smart wallet, ... March 30 th . The new ... York markets. Gino Pereira ... new ad campaign following the recent initial shipment of Wocket ...
(Date:3/20/2015)... -- NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or ... growing mobile commerce market, announces its biometric payment technology, ... featured in 2015 "I Want That" International CES Special, ... the DIY Network.   DIY,s "I Want ... site of the 2015 International CES for a firsthand ...
(Date:3/18/2015)... 18, 2015 As mobile payments become ... smart wallets and apps continue to be introduced into the ... the mobile payment industry in focus today are:  NXT-ID, Inc. ... BABA ), Apple Inc. (NASDAQ: AAPL ... Inc. (NASDAQ: FB ) NXT-ID, Inc. ...
Breaking Biology News(10 mins):NXT-ID's Wocket Smart Wallet to Launch New CNBC Regional TV Ad Campaign 2NXT-ID's Wocket Smart Wallet to Launch New CNBC Regional TV Ad Campaign 3NXT-ID's Wocket Biometric Smart Wallet to Air on "I Want That" International CES Special 2NXT-ID's Wocket Biometric Smart Wallet to Air on "I Want That" International CES Special 3Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 2Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 3Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 4Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 5Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 6
... its food or wait for dinner to arrive is linked to ... revealed. Prof. Rob McLaughlin has discovered that foraging behaviour of ... in the fish,s brain. "We found that the fish that ... telencephalons than the fish that sit along the shoreline and wait ...
... available in Chinese . College Park, MD (August ... powerful tools in molecular biology today. The devices, which can ... or genetic sequences, are employed in everything from forensic analysis ... Li and colleagues at Simon Fraser University in Burnaby, Canada ...
... Malfunction of a protein has been linked to a form of ... males, says Nasser K. Yaghi, a Texas A&M University magna cum ... research project at Harvard that has been published in the journal ... the condition is detected early in fetal development a treatment could ...
Cached Biology News:Brain size determines whether fish hunters or slackers 2Texas A&M spring graduate contributes to mental retardation research published in Nature 2
... dye terminators, template DNA, primers, salts or ... products have proved critical for both standard ... to work with dye terminator cycle sequencing ... The unique uniformity of the magnetic paeticles ...
Enodgenous alkaline phosphotase inhibitor. Levamisole solution is supplied in concentrated form (20x). The final concentration of levamisole in the substrate solution will be 1 mM....
uncoupling protein 2 (mitochondrial, proton carrier), mRNA (cDNA clone MGC:19567 IMAGE:4335185), complete cds...
Catch and Release® v2.0 Reversible Immunoprecipitation System...
Biology Products: